naphazoline has been researched along with Blindness in 1 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ortmaier, R | 1 |
| Resch, H | 1 |
| Stieböck, C | 1 |
| Stundner, O | 1 |
| Arlt, EM | 1 |
1 review available for naphazoline and Blindness
| Article | Year |
|---|---|
Purtscher's retinopathy after intramedullary nailing of a femoral shaft fracture in a 20-year old healthy female - report of a rare case and review of the literature.
Topics: Adrenergic alpha-Agonists; Anticoagulants; Blindness; Bone Nails; Drug Therapy, Combination; Female; | 2014 |